Wangsu Science & Technology Co., Ltd. (WANGSU) financials
SHZ · Technology · Software - Infrastructure · 1,364 employees · CEO Ke Hong
- Price
- CN¥15.35 +6.23%
- Market cap
- CN¥38.3B
- Enterprise value
- CN¥37.3B
- Last report
- Q3 '26 filed 2026-09-30
- Next report
- 2027-04-16
Valuation & key figures
- Market cap
- CN¥38.3B EV CN¥37.3B
- Revenue
- CN¥4.81B Trailing 12 months
- Revenue growth
- +12% FY2026 consensus
- Profit margin
- 15.8% Net income / revenue, TTM
- P/E
- 49.7× Forward 45.8× (FY2026)
- P/S
- 8.0× Price / sales, TTM
- EV / EBITDA
- 45.5× TTM
- Free cash flow
- CN¥786M Trailing 12 months
- Net income
- CN¥761M Trailing 12 months
- Revenue estimate
- CN¥5.23B FY2026 consensus
- Earnings
- 2027-04-16
- Dividend
- CN¥0.33 Per share, last 12 months
Key takeaways
Computed from the reported numbers - every statement carries the figure it rests on.
- Revenue growth accelerating: 15.9% year on yearQ3 '26 revenue CN¥1.32B, against an average of -6.6% over the four quarters before.
- Operating margin 15.3% (TTM), -0.3 pp on a year agoOperating income grew -2.3% while revenue grew -0.1%.
- Capex 5.2% of revenue (a year ago 3.3%)CN¥248M invested in the last 4 quarters (+57.3% on a year earlier). Free cash flow CN¥786M = 103.4% of net income.
- Returned CN¥206M to shareholders = 26.3% of free cash flowBuybacks CN¥0 (a year earlier CN¥2.83M), dividends CN¥206M, stock-based pay CN¥0 (TTM).
- Diluted share count up 0.1% in a year2.49B diluted shares in Q3 '26, 2.49B a year earlier.
- Net cash CN¥6.78BCash + short-term investments CN¥7.6B, debt incl. leases CN¥822M; a year ago net cash CN¥5.13B.
Last quarter: Q3 '26
Quarter ended 2026-09-30. Compared with the same quarter a year earlier and with the analyst consensus before the report.
Quarter vs a year ago
| Q3 '26 | Year ago | Change | |
|---|---|---|---|
| Revenue | CN¥1.32B | CN¥1.14B | +15.9% |
| Gross margin | 39.1% | 36.7% | +2.3 pp |
| Operating income | CN¥227M | CN¥96.1M | +136.1% |
| Operating margin | 17.2% | 8.4% | +8.7 pp |
| Net income | CN¥229M | CN¥244M | -5.9% |
| Diluted EPS | CN¥0.09 | CN¥0.10 | -5.9% |
| Operating cash flow | CN¥334M | CN¥493M | -32.1% |
| Capex | CN¥67.1M | CN¥62.7M | +7.0% |
| Free cash flow | CN¥267M | CN¥430M | -37.8% |
| R&D | CN¥102M | CN¥105M | -3.4% |
| Stock-based compensation | CN¥0 | CN¥0 | – |
Reported vs consensus
2026-10-26| Actual | Consensus | vs consensus | |
|---|---|---|---|
| Revenue | CN¥1.31B | CN¥1.32B | -0.8% |
From the report of 2026-10-26 for Q3 '26: revenue and the EPS analysts estimate (often adjusted), so it can differ from the EPS of the statements above.
EPS vs consensus
last 8 reportsRevenue
Where the money comes from - by business line and by region, quarter by quarter.
Revenue, operating income and growth
quarterlyMargins & cost structure
How much of each unit of revenue is left at each level - and where the costs go.
Margins
quarterlyCosts as % of revenue
quarterlyCash flow & capital allocation
Cash generated, what it is spent on, and what reaches shareholders.
Operating cash flow, capex, free cash flow
quarterlyUses of cash vs operating cash flow
fiscal yearsLast 4 quarters
cash flow statement- Operating cash flow
- CN¥1.03B
- Capex
- -CN¥248M
- Buybacks
- CN¥0
- Dividends
- -CN¥206M
- Acquisitions
- -CN¥94.5M
- Net debt issued
- CN¥153M
- Stock-based compensation
- CN¥0
- Free cash flow
- CN¥786M
- Returned to shareholders / FCF
- 26.3%
Share count and EPS
quarterly, dilutedBalance sheet
Liquidity, investments and debt at each quarter end.
Cash, investments and debt
quarter endsValuation & returns
Today's multiples against the company's own last five fiscal years; analyst targets and ratings.
Multiples and returns
TTM vs 5 fiscal years| Now | 5y average | Where today sits in the 5-year range | |
|---|---|---|---|
| P/E (TTM) | 49.7× | 54.2× | 31.1× – 99.1× |
| EV / EBITDA | 45.5× | 28.5× | 19.8× – 38.2× |
| EV / Sales | 7.7× | 3.9× | 2.2× – 5.1× |
| Price / FCF | 48.7× | 27.9× | 18.3× – 34.8× |
| Price / Book | 3.7× | 2.1× | 1.5× – 2.6× |
| FCF yield | 2.1% | 3.8% | 2.9% – 5.5% |
| Return on invested capital | 6.6% | 4.9% | 1.8% – 7.4% |
| Return on equity | 7.3% | 5.0% | 1.9% – 7.7% |
Outlook
Analyst consensus for the coming fiscal years and what it implies at today's price.
Consensus estimates
| Fiscal year | Revenue | Growth | EPS | Growth | P/E at today's price | Analysts (EPS) |
|---|---|---|---|---|---|---|
| FY2026 | CN¥5.23B | +12.2% | CN¥0.34 | +4.7% | 45.8× | 2 |
| FY2027 | CN¥5.96B | +14.0% | CN¥0.44 | +29.9% | 35.3× | 2 |
| FY2028 | CN¥6.79B | +13.8% | CN¥0.56 | +28.7% | 27.4× | 2 |
Financial statements
Every line of the income statement, balance sheet and cash flow statement - 12 quarters and 10 fiscal years, as values, as % of revenue or as growth.
Sources
Statements, segment revenue, metrics and estimates are standardised from the company's filings.
Data as of 2026-11-02